Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-up
- PMID: 40345949
- DOI: 10.1016/j.annonc.2025.01.023
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-up
Keywords: ESMO–EHA guideline; T-cell lymphoma; diagnosis; follow-up; treatment.
Similar articles
-
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up.Hemasphere. 2025 May 7;9(5):e70128. doi: 10.1002/hem3.70128. eCollection 2025 May. Hemasphere. 2025. PMID: 40342876 Free PMC article. No abstract available.
-
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol. 2024 May 14:S0923-7534(23)05074-3. doi: 10.1016/j.annonc.2023.11.010. Online ahead of print. Ann Oncol. 2024. PMID: 38839484 No abstract available.
-
Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol. 2024 Oct;35(10):840-859. doi: 10.1016/j.annonc.2024.06.003. Epub 2024 Sep 3. Ann Oncol. 2024. PMID: 39232987 No abstract available.
-
Angiocentric lymphomas (lymphomatous vasculitis).Semin Diagn Pathol. 2001 Feb;18(1):67-77. Semin Diagn Pathol. 2001. PMID: 11296995 Review.
-
Diagnosis, prevention and treatment of central nervous system involvement in peripheral t-cell lymphomas.Crit Rev Oncol Hematol. 2021 Nov;167:103496. doi: 10.1016/j.critrevonc.2021.103496. Epub 2021 Oct 12. Crit Rev Oncol Hematol. 2021. PMID: 34653598 Review.
Cited by
-
A Finnish nationwide population-based study on the survival of patients with peripheral T-cell lymphoma.Sci Rep. 2025 Jul 25;15(1):27077. doi: 10.1038/s41598-025-12596-1. Sci Rep. 2025. PMID: 40715325 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources